Cargando…
ICER's timelines for assessments extended due to COVID-19
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7140250/ https://www.ncbi.nlm.nih.gov/pubmed/32288506 http://dx.doi.org/10.1007/s40274-020-6689-5 |
_version_ | 1783518952482144256 |
---|---|
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7140250 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-71402502020-04-08 ICER's timelines for assessments extended due to COVID-19 PharmacoEcon Outcomes News News Item Springer International Publishing 2020-04-04 2020 /pmc/articles/PMC7140250/ /pubmed/32288506 http://dx.doi.org/10.1007/s40274-020-6689-5 Text en © Springer International Publishing AG 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | News Item ICER's timelines for assessments extended due to COVID-19 |
title | ICER's timelines for assessments extended due to COVID-19 |
title_full | ICER's timelines for assessments extended due to COVID-19 |
title_fullStr | ICER's timelines for assessments extended due to COVID-19 |
title_full_unstemmed | ICER's timelines for assessments extended due to COVID-19 |
title_short | ICER's timelines for assessments extended due to COVID-19 |
title_sort | icer's timelines for assessments extended due to covid-19 |
topic | News Item |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7140250/ https://www.ncbi.nlm.nih.gov/pubmed/32288506 http://dx.doi.org/10.1007/s40274-020-6689-5 |